litlas
ログインアカウント作成

Carsten Denkert

2001–2025 年に発表

288
論文数
64,961
被引用数
117
h 指数
269
i10 指数

被引用数

Carsten Denkert の年別被引用数1961 年: 被引用 1 件1971 年: 被引用 1 件1980 年: 被引用 1 件1982 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 7 件2001 年: 被引用 2 件2002 年: 被引用 4 件2003 年: 被引用 23 件2004 年: 被引用 44 件2005 年: 被引用 64 件2006 年: 被引用 48 件2007 年: 被引用 57 件2008 年: 被引用 91 件2009 年: 被引用 130 件2010 年: 被引用 173 件2011 年: 被引用 187 件2012 年: 被引用 242 件2013 年: 被引用 288 件2014 年: 被引用 396 件2015 年: 被引用 500 件2016 年: 被引用 639 件2017 年: 被引用 769 件2018 年: 被引用 680 件2019 年: 被引用 2,445 件2020 年: 被引用 3,018 件2021 年: 被引用 3,306 件2022 年: 被引用 2,895 件2023 年: 被引用 2,279 件2024 年: 被引用 3,398 件2025 年: 被引用 1,681 件2026 年: 被引用 71 件1962〜1970 年は被引用が無いため表示していません1972〜1979 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません1983〜1985 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,965 件、この内訳の 19.8%中国: 引用元論文 3,904 件、この内訳の 15.6%ドイツ: 引用元論文 1,557 件、この内訳の 6.2%イタリア: 引用元論文 1,330 件、この内訳の 5.3%イギリス: 引用元論文 1,228 件、この内訳の 4.9%フランス: 引用元論文 908 件、この内訳の 3.6%スペイン: 引用元論文 777 件、この内訳の 3.1%日本: 引用元論文 734 件、この内訳の 2.9%カナダ: 引用元論文 710 件、この内訳の 2.8%オーストラリア: 引用元論文 688 件、この内訳の 2.8%韓国: 引用元論文 616 件、この内訳の 2.5%ベルギー: 引用元論文 560 件、この内訳の 2.3%
0%19.8%その他 28.2%

機関

分野

  • Medicine46.3%
  • Biochemistry, Genetics and Molecular Biology41.1%
  • Immunology and Microbiology4.9%
  • Computer Science3.6%
  • Engineering1.1%
  • Materials Science0.7%
  • その他2.3%

トピック

  • Cancer Immunotherapy and Biomarkers7.3%
  • Breast Cancer Treatment Studies6.5%
  • HER2/EGFR in Cancer Research3.2%
  • Cancer Cells and Metastasis3.2%
  • Immunotherapy and Immune Responses3%
  • Cancer Genomics and Diagnostics2.3%
  • その他74.5%

共著者

全論文

検索で開く
  1. Pembrolizumab for Early Triple-Negative Breast Cancer

    著者: Peter Schmid, Javier Cortés, Lajos Pusztai, Heather L. McArthur, Sherko Kümmel, Jonas Bergh, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Theodoros Foukakis, Peter A. Fasching, Fátima Cardoso, Michael Untch, Liyi Jia, Vassiliki Karantza, Jing Zhao, Gursel Aktan, Rebecca Dent, Joyce O’Shaughnessy - New England Journal of Medicine 2020 被引用: 3,116

  2. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

    著者: Peter Schmid, Javier Cortes, Rebecca Dent, Lajos Pusztai, Heather McArthur, Sherko Kümmel, Jonas Bergh, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Michael Untch, Peter A. Fasching, Fatima Cardoso, Jay Andersen, Debra Patt, Michael Danso, Marta Ferreira, Marie-Ange Mouret-Reynier, Seock-Ah Im, Jin-Hee Ahn, Maria Gion, Sally Baron-Hay, Jean-François Boileau, Yu Ding, Konstantinos Tryfonidis, Gursel Aktan, Vassiliki Karantza, Joyce O’Shaughnessy - New England Journal of Medicine 2022 被引用: 1,145

  3. Breast cancer

    著者: Sibylle Loibl, Philip Poortmans, Monica Morrow, Carsten Denkert, Giuseppe Curigliano - The Lancet 2021 被引用: 1,620

  4. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    著者: Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 被引用: 3,136

  5. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

    著者: Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Bianca Lederer, Barbara Ingold Heppner, Karsten E. Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto, Wolfgang Schmitt, Jens‐Uwe Blohmer, Thomas Karn, Berit M. Pfitzner, Sherko Kümmel, Knut Engels, Andreas Schneeweiß, Arndt Hartmann, Aurelia Noske, Peter A. Fasching, Christian Jackisch, Marion van Mackelenbergh, Hans‐Peter Sinn, Christian Schem, Claus Hanusch, Michael Untch, Sibylle Loibl - The Lancet Oncology 2017 被引用: 2,125

  6. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: Sibylle Loibl, Fabrice André, Thomas Bachelot, Carlos H. Barrios, Jonas Bergh, Harold J. Burstein, Maria João Cardoso, Lisa A. Carey, Shaheenah Dawood, Lucia Del Mastro, Carsten Denkert, Eva Maria Fallenberg, Prudence A. Francis, H. Gamal‐El‐Din, Karen A. Gelmon, Charles E. Geyer, Michael Gnant, Valentina Guarneri, Sudeep Gupta, Sung‐Bae Kim, David Krug, Miguel Martín, Icro Meattini, Monica Morrow, Wolfgang Janni, Shani Paluch–Shimon, Ann H. Partridge, Philip Poortmans, Lajos Pusztai, Meredith M. Regan, Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 被引用: 844

  7. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

    著者: Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer, Serban Dan Costa, Holger Eidtmann, Peter A. Fasching, Bernd Gerber, W. Eiermann, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Gottfried E. Konecny, Carsten Denkert, Valentina Nekljudova, Keyur Mehta, Sibylle Loibl - Journal of Clinical Oncology 2012 被引用: 2,674

  8. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: Harold J. Burstein, Giuseppe Curigliano, Beat Thürlimann, William P. Weber, Philip Poortmans, Meredith M. Regan, H.-J. Senn, Eric P. Winer, Michael Gnant, Stephan Aebi, Fabrice André, Carlos Barrios, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel Morales, Sara Y. Brucker, Harold J. Burstein, David Cameron, Fátima Cardoso, Lisa A. Carey, Boon Chua, Eva Ciruelos, Marco Colleoni, Giuseppe Curigliano, Suzette Delaloge, Carsten Denkert, Peter Dubsky, Bent Ejlertsen, Florian Fitzal, Prudence A. Francis, Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  9. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    著者: Torsten O. Nielsen, Samuel Leung, David L. Rimm, Andrew Dodson, Balázs Ács, Sunil Badve, Carsten Denkert, Matthew J. Ellis, Susan Fineberg, Margaret Flowers, Hans Kreipe, Anne‐Vibeke Lænkholm, Hongchao Pan, Frédérique Penault‐Llorca, Mei‐Yin C. Polley, Roberto Salgado, Ian E. Smith, Tomoharu Sugie, John M.S. Bartlett, Lisa M. McShane, Mitch Dowsett, Daniel F. Hayes - JNCI Journal of the National Cancer Institute 2020 被引用: 733

  10. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

    著者: Carsten Denkert, Fenja Seither, Andreas Schneeweiß, Theresa Link, Jens‐Uwe Blohmer, Marianne Just, Pauline Wimberger, A Forberger, Hans Tesch, Christian Jackisch, Sabine Schmatloch, Mattea Reinisch, Erich Solomayer, Wolfgang Schmitt, Claus Hanusch, Peter A. Fasching, Kristina Lübbe, Christine Solbach, Jens Huober, Kerstin Rhiem, Frederik Marmé, Toralf Reimer, Marcus Schmidt, Bruno V. Sinn, Wolfgang Janni, Elmar Stickeler, Laura L. Michel, Oliver Stötzer, Eric Hahnen, Jenny Furlanetto, Sabine Seiler, Valentina Nekljudova, Michael Untch, Sibylle Loibl - The Lancet Oncology 2021 被引用: 561

  11. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    著者: Sherene Loi, Damien Drubay, Sylvia Adams, Giancarlo Pruneri, Prudence A. Francis, Magali Lacroix‐Triki, Heikki Joensuu, Maria Vittoria Dieci, Sunil Badve, Sandra Demaria, Robert J. Gray, Elisabetta Munzone, Jérôme Lemonnier, Christos Sotiriou, Martine Piccart, Pirkko‐Liisa Kellokumpu‐Lehtinen, Andrea Vingiani, Kathryn P. Gray, Fabrice André, Carsten Denkert, Roberto Salgado, Stefan Michiels - Journal of Clinical Oncology 2019 被引用: 891

  12. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

    著者: S. Loibl, Michael Untch, Nicole Burchardi, Jens Huober, Bruno V. Sinn, Jens‐Uwe Blohmer, Eva‐Maria Grischke, Jenny Furlanetto, Hans Tesch, Claus Hanusch, Knut Engels, Mahdi Rezai, Christian Jackisch, Wolfgang Schmitt, Gϋnter von Minckwitz, Jörg Thomalla, Sherko Kümmel, Beate Rautenberg, Peter A. Fasching, Karsten E. Weber, Kerstin Rhiem, Carsten Denkert, Andreas Schneeweiß - Annals of Oncology 2019 被引用: 694

  13. Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

    著者: Carsten Denkert, Sibylle Loibl, Aurelia Noske, Marc Roller, Berit Müller, Martina Komor, Jan Budczies, Silvia Darb‐Esfahani, Ralf Kronenwett, Claus Hanusch, Christian von Törne, Wilko Weichert, Knut Engels, Christine Solbach, Iris Schrader, Manfred Dietel, Gϋnter von Minckwitz - Journal of Clinical Oncology 2009 被引用: 1,783

  14. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

    著者: Sibylle Loibl, Andreas Schneeweiß, Jens Huober, Michael Braun, Julia Rey, Jens‐Uwe Blohmer, Jenny Furlanetto, D M Zahm, Claus Hanusch, Jörg Thomalla, Christian Jackisch, Peter Staib, Theresa Link, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Valentina Nekljudova, Carsten Denkert, Michael Untch - Annals of Oncology 2022 被引用: 244

  15. Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer

    著者: Balaji Virassamy, Franco Caramia, Peter Savas, Sneha Sant, Jianan Wang, Susan N. Christo, Ann Byrne, Kylie Clarke, Emmaline Brown, Zhi L. Teo, Bianca von Scheidt, David Freestone, Luke C. Gandolfo, Karsten E. Weber, Julia Teply‐Szymanski, Ran Li, Stephen J. Luen, Carsten Denkert, Sibylle Loibl, Olivia Lucas, Charles Swanton, Terence P. Speed, Phillip K. Darcy, Paul J. Neeson, Laura K. Mackay, Sherene Loi - Cancer Cell 2023 被引用: 221

  16. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver, Mónica V. Estrada, Paula I. González-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G. G. M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes A. Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nucíforo, Laura Comerma, E. Aubrey Thompson, Sunil R. Lakhani, Seong-Rim Kim, Stuart J. Schnitt, Cécile Colpaert, Christos Sotiriou, Stefan Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  17. Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer

    著者: Peter Schmid, Javier Cortes, Rebecca Dent, Heather L. McArthur, Lajos Pusztai, Sherko Kümmel, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Seock‐Ah Im, Michael Untch, Peter A. Fasching, Marie‐Ange Mouret‐Reynier, Theodoros Foukakis, Marta Ferreira, Fátima Cardoso, Xuan Zhou, Vassiliki Karantza, Konstantinos Tryfonidis, Gursel Aktan, Joyce O’Shaughnessy - New England Journal of Medicine 2024 被引用: 419

  18. Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    著者: Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K. Darcy, Mark J. Smyth, Sherene Loi - Nature Reviews Clinical Oncology 2015 被引用: 904

  19. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

    著者: Carsten Denkert, Cornelia Liedtke, Andrew Tutt, Gϋnter von Minckwitz - The Lancet 2016 被引用: 876

  20. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    著者: Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, Pirkko Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou - Annals of Oncology 2014 被引用: 1,270

  21. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

    著者: Sibylle Loibl, Frederik Marmé, Miguel Martín, Michael Untch, Hervé Bonnefoi, Sung‐Bae Kim, Harry D. Bear, Nicole McCarthy, Mireia Melé, Karen A. Gelmon, José Á. García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, María Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Gϋnter von Minckwitz - Journal of Clinical Oncology 2021 被引用: 324

  22. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

    著者: Balázs Győrffy, András Lánczky, Aron C. Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltán Szállási - Breast Cancer Research and Treatment 2009 被引用: 4,344

  23. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    著者: Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, H. El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Verónica Bautista, José Fernando do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista ほか 454 名 - npj Breast Cancer 2021 被引用: 275

  24. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: Giuseppe Curigliano, Harold J. Burstein, Michael Gnant, Sibylle Loibl, David Cameron, Meredith M. Regan, Carsten Denkert, Philip Poortmans, William P. Weber, Beat Thürlimann, Stefan Aebi, Meteb Al‐Foheidi, Fabrice André, Mykola Anikusko, R. Badwe, A.V. Barrio, Carlos H. Barrios, Jonas Bergh, Hervé Bonnefoi, Daniela Morales, Sara Y. Brucker, Harold J. Burstein, Carlos Caldas, David Cameron, F. Cardoso, Maria João Cardoso, L.A Carey, Stephen Chia, Charlotte E. Coles, J. Cortes, Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221